Cost-Effectiveness of Omalizumab in Chronic Idiopathic Urticaria Refractory to H1-Antihistamines in Turkey. 2014

M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
Hacettepe University, Ankara, Turkey.

UI MeSH Term Description Entries

Related Publications

M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
August 2005, Cutis,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
April 2020, Journal of investigational allergology & clinical immunology,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
December 1993, Annals of allergy,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
January 2002, Clinical allergy and immunology,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
May 2003, Annales de dermatologie et de venereologie,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
March 2021, Dermatologic therapy,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
November 2014, The Cochrane database of systematic reviews,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
June 2022, Postepy dermatologii i alergologii,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
December 2018, Turk pediatri arsivi,
M Tatar, and S Sezen, and A Senturk, and M M Balp, and M Saylan, and A Keskinaslan
January 2021, Dermatologic therapy,
Copied contents to your clipboard!